地形图引导的准分子激光原位角膜磨镶术与角膜屈光透镜切除术(KLEx)的三个月综合结果:一项前瞻性对侧研究。
Three-Month Comprehensive Outcomes of Topography-Guided LASIK Versus Keratorefractive Lenticule Extraction (KLEx): A Prospective Contralateral Study.
作者信息
Moin Kayvon A, Manion Garrett N, Pandiri Srujay, Hoopes Phillip C, Moshirfar Majid
机构信息
Hoopes Vision Research Center, Hoopes Vision, 11820 S State St #200, Draper, UT, 84020, USA.
Creighton University School of Medicine, Omaha, NE, USA.
出版信息
Ophthalmol Ther. 2024 Aug;13(8):2265-2284. doi: 10.1007/s40123-024-00987-y. Epub 2024 Jul 1.
INTRODUCTION
The aim of this study was to compare outcomes of topography-guided laser-assisted in situ keratomileusis (TG-LASIK) and small incision lenticule extraction (SMILE®) for correcting myopia and myopic astigmatism.
METHODS
In this prospective, randomized contralateral study, 34 patients (68 eyes) received TG-LASIK in one eye, and SMILE in their fellow eye. Efficacy, safety, predictability, higher-order aberrations, corneal tomography, biomechanics, and patient-reported outcomes (PROs) were assessed preoperatively and up to 3 months postoperatively.
RESULTS
Both platforms showed comparable efficacy at 3 months (TG-LASIK 1.08 ± 0.19; SMILE 0.98 ± 0.17, p = 0.055). However, TG-LASIK demonstrated quicker visual recovery, with 63% and 89% achieving uncorrected distance visual acuity (UDVA) of 20/16 or better at 1 day and 1 week, respectively, compared to SMILE (34% and 63%; p < 0.05). Safety index at 3 months did not significantly differ between TG-LASIK and SMILE (p = 0.223). TG-LASIK and SMILE had 44% and 56% of eyes within 0.13 D of spherical equivalent (SEQ) target, respectively. SMILE induced more total higher-order aberrations (HOAs), vertical coma, and oblique trefoil than TG-LASIK at 3 months (p < 0.05). Both platforms showed similar increases in epithelial remodeling, but SMILE induced thicker epithelium than TG-LASIK at the 7.0-mm nasal zonal area. No significant differences were found in corneal hysteresis (CH) or corneal resistance factor (CRF) at 3 months (p > 0.05). Reported symptoms of glare, halos, rings, starbursts, or dry eye did not significantly differ between groups at 3 months (p > 0.05). Overall, 59% of patients preferred their TG-LASIK treated eye at 1 month, but 65% of patients had no specific eye preference at 3 months.
CONCLUSION
TG-LASIK and SMILE demonstrate excellent and comparable efficacy, safety, and predictability at 3 months, but TG-LASIK offers faster postoperative visual recovery at 1 day and 1 week. TG-LASIK induces fewer HOAs than SMILE, but both procedures affect corneal biomechanics similarly.
TRIAL REGISTRATION
ClincialTrials.gov identifier, NCT05611294.
引言
本研究旨在比较地形图引导的准分子原位角膜磨镶术(TG-LASIK)和小切口基质透镜切除术(SMILE®)矫正近视和近视散光的效果。
方法
在这项前瞻性、随机对照对侧眼研究中,34例患者(68只眼)一只眼接受TG-LASIK手术,另一只眼接受SMILE手术。在术前及术后3个月内评估疗效、安全性、可预测性、高阶像差、角膜地形图、生物力学以及患者报告的结局(PROs)。
结果
两种手术平台在术后3个月时显示出相当的疗效(TG-LASIK 1.08±0.19;SMILE 0.98±0.17,p = 0.055)。然而,TG-LASIK显示出更快的视力恢复,与SMILE相比,分别有63%和89%的患者在术后1天和1周时未矫正远视力(UDVA)达到20/16或更好(SMILE为34%和63%;p<0.05)。TG-LASIK和SMILE在术后3个月时的安全指数无显著差异(p = 0.223)。TG-LASIK和SMILE分别有44%和56%的眼的等效球镜度(SEQ)在目标值的0.13D范围内。术后3个月时,SMILE比TG-LASIK诱导产生更多的总高阶像差(HOAs)、垂直彗差和斜三叶像差(p<0.05)。两种手术平台在上皮重塑方面均有相似程度的增加,但在鼻侧7.0mm区域,SMILE诱导产生的上皮比TG-LASIK更厚。术后3个月时,角膜滞后(CH)或角膜阻力因子(CRF)无显著差异(p>0.05)。在术后3个月时,两组报告的眩光、光晕、光环、星芒或干眼症状无显著差异(p>0.05)。总体而言,59%的患者在术后1个月时更喜欢接受TG-LASIK手术的眼,但在术后3个月时,65%的患者没有特定的眼偏好。
结论
TG-LASIK和SMILE在术后3个月时显示出优异且相当的疗效、安全性和可预测性,但TG-LASIK在术后1天和1周时视力恢复更快。TG-LASIK比SMILE诱导产生的HOAs更少,但两种手术对角膜生物力学的影响相似。
试验注册
ClinicalTrials.gov标识符,NCT05611294。
相似文献
J Cataract Refract Surg. 2019-6-10
本文引用的文献
BMC Ophthalmol. 2023-4-21
Klin Monbl Augenheilkd. 2020-12